A paradigm shift in the surgical treatment of cancer
Next-generation miniaturized sensors
Power of AI to combine diagnostic and surgical images
New breakthrough cancer-targeted imaging agents
We are using next-generation miniaturized sensors to enable the engineering of miniaturized probes suitable in scale for the small laparoscopic ports used in state-of-the-art robotic surgery
New breakthrough cancer-targeted imaging agents
Power of AI to combine diagnostic and surgical images
New breakthrough cancer-targeted imaging agents
Combined with new cancer-targeted imaging agents, such as PSMA, our probes can define entirely novel radio-guided surgical applications, promising a paradigm shift in the surgical treatment of cancer
Power of AI to combine diagnostic and surgical images
Power of AI to combine diagnostic and surgical images
Power of AI to combine diagnostic and surgical images
By using the same cancer-target imaging agents, data from pre-operative scans along with intra-operative data from Lightpoint’s probes can be combined with AI to offer never-seen-before visualization of the surgical location and extent of any cancer
Improving outcomes for patients
Power of AI to combine diagnostic and surgical images
Power of AI to combine diagnostic and surgical images
All aiding surgeons to find and remove cancer, transforming outcomes for patients and saving costs for healthcare systems
Latest news
First SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
Lightpoint Medical has entered into an agreement to be acquired by Telix Pharmaceuticals
Lightpoint Medical has entered into an agreement to be acquired by Telix Pharmaceuticals
Lightpoint today announces a world-first bladder cancer sentinel lymph node (SLN) procedure with SENSEI®, Telix's miniature robotic-assisted gamma probe used to detect radiation in patients and guide surgery. The patient was operated on at Hospital del Mar in Barcelona, Spain.
Lightpoint Medical has entered into an agreement to be acquired by Telix Pharmaceuticals
Lightpoint Medical has entered into an agreement to be acquired by Telix Pharmaceuticals
Lightpoint Medical has entered into an agreement to be acquired by Telix Pharmaceuticals
Telix to expand late-stage urologic pipeline with acquisition of Lightpoint Medical and its radioguided surgery business
UMC, Utrecht publish first-in-woman clinical data for SENSEI® in cervical cancer surgery
Lightpoint Medical has entered into an agreement to be acquired by Telix Pharmaceuticals
UMC, Utrecht publish first-in-woman clinical data for SENSEI® in cervical cancer surgery
Congratulations to Professor Ronald Zweemer & Dr Kees Gerestein for publication of their clinical study results using SENSEI® in robot-assisted sentinel lymph node detection.
First SENSEI® procedure in robotic prostate cancer surgery in the US
New SENSEI® study launched in robot-assisted colorectal cancer surgery
UMC, Utrecht publish first-in-woman clinical data for SENSEI® in cervical cancer surgery
Congratulations to the team at UCLA Health in California for first use of SENSEI® in robot-assisted prostate cancer surgery in the US.
New SENSEI® study launched in robot-assisted colorectal cancer surgery
New SENSEI® study launched in robot-assisted colorectal cancer surgery
New SENSEI® study launched in robot-assisted colorectal cancer surgery
Professor Manish Chand launches clinical feasibility study using SENSEI® in robot-assisted colorectal cancer surgery at University College Hospital, London.
The incidence of cancer is growing rapidly worldwide
+18 million
Lack of tools to accurately detect cancer intraoperatively
Rising over 60% by 2030
+18 million new cases of cancer will be diagnosed globally and the disease will account for one in six deaths
Rising over 60% by 2030
Lack of tools to accurately detect cancer intraoperatively
Rising over 60% by 2030
The incidence of cancer is forecast to rise by over 60% by 2030 with over 24 million new cases each year worldwide
Robots have transformed surgery
Lack of tools to accurately detect cancer intraoperatively
Lack of tools to accurately detect cancer intraoperatively
Robots have transformed surgery in recent decades with minimally-invasive, robot-assisted cancer surgery now dominating clinical practice
Lack of tools to accurately detect cancer intraoperatively
Lack of tools to accurately detect cancer intraoperatively
Lack of tools to accurately detect cancer intraoperatively
However, despite the robotic advances, cancer is often left behind or, conversely, healthy tissue is needlessly removed, increasing the need for further drug treatment, radiotherapy, & surgery